Last reviewed · How we verify

NCT02421419

Pain With Trigger Finger Injection: A Comparison of Steroid Alone Versus Steroid/Lidocaine Mixture

Terminated Phase 4 Results posted Last updated 26 September 2018
What this trial tests

Phase 4 trial testing Dexamethasone Sodium Phosphate in Trigger Finger Disorder in 26 participants. Terminated before completion.

Timeline
1 June 2015
Primary endpoint
25 January 2017
25 January 2017

Quick facts

Lead sponsorKenneth Taylor, M.D.
PhasePhase 4
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment26
Start date1 June 2015
Primary completion25 January 2017
Estimated completion25 January 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Kenneth Taylor, M.D.

Who can join

Adults 18 to 90, any sex, with Trigger Finger Disorder. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

This research is being done to compare pain relief and efficacy of trigger finger injection using a combination of lidocaine/corticosteroid versus corticosteroid injection alone versus corticosteroid/saline combination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexamethasone Sodium Phosphate

Trials testing the same drug.

Other Kenneth Taylor, M.D. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02421419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing